Results 261 to 270 of about 413,694 (387)

The global regulatory landscape for combined vaccines: A comparative case study of registration strategies for diphtheria-tetanus-pertussis-containing vaccines. [PDF]

Vaccine
He X, Pu Y, Li Z, Huan S, Yang Y.
europepmc   +1 more source

Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney

Liver International, Volume 45, Issue 7, July 2025.
ABSTRACT Introduction The hepatitis E virus (HEV; species Paslahepevirus balayani) is a common human pathogenic and zoonotic virus that can cause both acute fulminant and chronic hepatitis. Despite its reputation as a hepatotropic virus, HEV infection is also associated with a number of extrahepatic diseases, including kidney disorders.
Avista Wahid, Nele Meyer, Christine Wundes, Lucas Hüffner, Saskia Janshoff, Nicola Frericks, Martina Friesland, Katja Dinkelborg, Elmira Aliabadi, Fenja Laue, Markus Cornberg, Benjamin Maasoumy, Birgit Bremer, Sven Pischke, Tobias Müller, Julian Zur Schulze Wiesch, Julia Benckert, Rainer G. Ulrich, Svenja Hardtke, Petra Dörge, Florian Vondran, Ansgar Lohse, Michael Peter Manns, Daniel Todt, Heiner Wedemeyer, Thomas Pietschmann, Eike Steinmann, André Gömer, Patrick Behrendt   +28 more
wiley   +1 more source

Sheep immune response against a novel recombinant enterotoxemia and infectious necrotic hepatitis vaccine in Türkiye. [PDF]

BMC Vet Res
Ekinoğlu DN, Çelik V, Gül E, Kalender H, Öngör H, Çetinkaya B.   +5 more
europepmc   +1 more source

Hospitalisations With Cryoglobulin‐Related Diseases in Spain Over 25 Years

Liver International, Volume 45, Issue 7, July 2025.
ABSTRACT Background The epidemiology of cryoglobulinemia in Spain has likely changed following the widespread adoption of direct‐acting antivirals (DAAs) since 2015 for the treatment of hepatitis C virus (HCV) infection, the principal cause of mixed cryoglobulinemia (MC).
Mario Martín‐Portugués, Jorge Esteban‐Sampedro, Carmen de Mendoza, Guillermo Ruiz‐Irastorza, Ana Royuela, Alfonso Ortega‐de la Puente, Marina de la Cruz‐Echeandía, Xiomara Patricia Blanco‐Valencia, Vicente Soriano, Víctor Moreno‐Torres   +9 more
wiley   +1 more source

Effectiveness of catch-up vaccination from 2009 to 2011 on incidence of hepatitis B in Guangzhou, China: a time series analysis. [PDF]

BMC Public Health
Ming BW, Liu WH, Li L, Zhang JL, Liu J, Ma JJ, Huang HN, Zhang ZB, Ou CQ.   +8 more
europepmc   +1 more source

Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement

Medical Journal of Australia, Volume 222, Issue 11, Page 571-578, June 2025.
Abstract Introduction Buruli ulcer, caused by Mycobacterium ulcerans, is increasing in incidence and spreading to new areas in southeast Australia. With increasing experience and emerging evidence, this consensus statement considers contemporary data to provide up‐to‐date recommendations to clinicians who may encounter this disease.
Stephen Muhi, Victoria RV Cox, Matthew O'Brien, Jonathan T Priestley, Jodie Hill, Adrian Murrie, Anthony McDonald, Peter Callan, Grant A Jenkin, N Deborah Friedman, Kasha P Singh, Callum Maggs, Peter Kelley, Eugene Athan, Paul DR Johnson, Daniel P O'Brien   +15 more
wiley   +1 more source

Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol. [PDF]

PLoS One
Bhat KD, Bhattacharya H, Jayaraman Y, Kanungo S, Pattnaik M, Pati S, Bhattacharya D.   +6 more
europepmc   +1 more source

Reactivity pattern of a human monoclonal antibody against recombinant hepatitis B vaccine to hbsag immune escape mutants

, 2000
Michel P. Cooreman, C. M. G. Sünnen, Lieven Verhoye, Mark H. van Roosmalen, Wilma P. Paulij, Geert Leroux‐Roels   +5 more
openalex   +1 more source

Roadmap to Nanomedical Applications: Nanotoxicology and In Vitro Guidelines for Lanthanide‐Doped Luminescence Nanothermometers

Advanced NanoBiomed Research, Volume 5, Issue 6, June 2025.
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska, Andre G. Skirtach, Anna M. Kaczmarek   +2 more
wiley   +1 more source

Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers. [PDF]

Ann Fam Med
Williams AL, Newman RS.
europepmc   +1 more source